Docetaxel or Paclitaxel

DRUG2 trials

Sponsors

Latin American Cooperative Oncology Group, Sichuan Baili Pharmaceutical Co., Ltd.

Conditions

Breast CancerUrothelial Carcinoma

Phase 3

Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer

Active, not recruitingNCT04540692

Latin American Cooperative Oncology GroupBreast Cancer

Start: 2021-01-12End: 2030-10-01Updated: 2026-09-02

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01)

RecruitingNCT06857175

Sichuan Baili Pharmaceutical Co., Ltd.Urothelial Carcinoma

Start: 2025-03-25End: 2027-12-01Target: 508Updated: 2026-04-20

Related Papers

Abstract OT2-22-02: Sequencing of anthracyclines and taxanes during neoadjuvant therapy of locally advanced HER2-negative breast cancer (NEOSAMBA Study/LACOG 0419)

Cancer Research2023-03-012 citations